Anemia of pregnancy and helicobacteriosis: features of the clinical and laboratory course

Clinical case

Authors

DOI:

https://doi.org/10.18370/2309-4117.2023.69.53-58

Keywords:

anemia, pregnant women, helicobacteriosis, Helicobacter pylori, clinical case

Abstract

A clinical case of the course of pregnancy by trimesters of gestation, childbirth, postpartum (early, late) in a woman with anemia and helicobacteriosis is described. The materials of the medical documentation were analyzed, the peculiarities of the course of pregnancy, childbirth, the postpartum period, laboratory indicators, echography, fibrogastroduodenoscopy were determined.
A 32-year-old pregnant woman was hospitalized at 33–34 weeks’ gestation, IV pregnancy. According to the clinical and laboratory examination, B12-folate-iron-deficiency anemia was diagnosed against the background of Helicobacter pylori (Hp) infection (titers of total IgG, IgA, IgM antibodies to Hp antigens (coefficient of positivity) were 7.65). The patient received anti-anemic, nutrient therapy before and after childbirth. Childbirth was termed and physiological. The child was born with a body weight of 3000 g and an Apgar score of 8 points.
The woman was examined again 2 months after labor. Anemia of II degree was diagnosed, the Hp coefficient of positivity was increased up to 14.57. It was prescribed anti-anemic therapy aimed at eradicating Hp in accordance with the Maastricht V Consensus (2015) and stabilizing metabolic processes. Two months after treatment, the Hp coefficient of positivity decreased by 2.3 times and the levels of hemoglobin, ferritin, vitamin B12, and folic acid increased to reference values.
Conclusions. It is advisable to determine the total titers of IgG, IgA, IgM antibodies to Hp antigens (coefficient of positivity) as the etiological factors of anemia in pregnant women, especially with diseases of the gastrointestinal tract, hepatobiliary system and resistance to anti-anemic therapy. Helicobacteriosis affects the exchange of iron and vitamins of group B, while anemia occurs with more severe manifestations and is resistant to anti-anemic drugs.
Full treatment of pregnant women with helicobacteriosis is difficult due to the possible risk of negative effects of etiotropic drugs on the fetus. Therefore, it is important to plan a pregnancy, since timely detection of infectious factors before pregnancy and full-fledged therapy help to reduce the frequency of gestational complications.

Author Biographies

V.P. Mishchenko, Odesa National Medical University, Odessa

MD, professor, Department of Obstetrics and Gynecology

V.V. Mishchenko, ONMU, Odesa

MD, professor, Surgery Department

I.V. Rudenko, Saudi German Hospital, Dubai

MD, professor

I.L. Holovatyuk-Yuzefpolska, ONMU; Maternity House No. 1, Odesa

PhD, assistant, Department of Obstetrics and Gynecology;
director

References

  1. Zherebak, N.M. Gnatko, O.P., Skuryatina, N.G. “The influence of helicobacter pylori on the course of early pregnancy in pregnant women with chronic gastritis.” Immunology and Allergy: Science and Practice 1(11) (2020): 72–79. DOI: 10.37321/immunology.2020.01-10
  2. Palii, I.G. “Standards of diagnosis and treatment of aciddependent and Helicobacter pylori-associated diseases” Ukrainian Medical Journal 3 (119) (2017): 90–94. Available from: [www.umj.com.ua], last accessed 06.10.2023
  3. Shvets, O.V., Bondarenko, A., Agibalov, A.N., et al. “The results of a multicenter study of the effectiveness of Helicobacter pylori eradication, conducted in accordance with the recommendations of the Maastricht consensus V.” Modern gastroenterology 1 (105) (2019): 87–92. DOI: https://doi.org/10.30978/MG-2019-1-87
  4. Ansari, S., Yamaoka, Y. “Current understanding and management of Helicobacter pylori infection: an updated appraisal.” F1000Res 7. (2018); F1000 FacultyRev–721.
  5. Benson, C.S., Shah, A., Frise, M.C., et al. “Iron deficiency anaemia in pregnancy: A contemporary review.” Obstetric medicine 14 (2) (2021): 67–76. Available from: [https://doi.org/10.1177/1753495X20932426], last accessed 06.10.2023.
  6. Brenner, A., Roberts, I., Balogun, E., et al. “Postpartum haemorrhage in anaemic women: assessing outcome measures for clinical trials.” Trials 23 (1) (2022): 220. Available from: [https://doi.org/10.1186/s13063-022-06140-z], last accessed 06.10.2023.
  7. Camilo, V., Sugiyama, T., Touati, E. “Pathogemesis of Helicobacter pylori infection.” Helicobacter 22, Suppl. 1. (2017): doi:10.1111/hel.12405.
  8. Cardaropoli,S., Piazzese, A., Piccoli,E., et al. “Is Helicobacter pylori infection a riskfactor for miscarriage?” Placenta 34 (2013): 37–38. DOI: 10.1016/j.placenta.2013.06.112
  9. El–Serag , H.B, Kao, J.Y., Kanwal, F., et al. “Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.” Clin Gastroenterol Hephatol. 16 (7) (2018): 992–1002. Doi: 10.1016/j.cgh.2018.03.013. Epub 2018 Mar 17.
  10. Erlandsson, L., Masoumi, Z., Hansson, L.R., et al. “The roles of free iron, heme, haemoglobin, and the scavenger proteins haemopexin and alpha-1- microglobulin in preeclampsia and fetal growth restriction.” Journal of internal medicine 290 (5) (2021): 952–968. Available from: [https://doi.org/10.1111/joim.13349], last accessed 06.10.2023.
  11. Ford, A.C., Gurusamy, K.S., Delaney, B., et al. “Eradication therapy for pertic ulcer disease in Helicobacter pylori positive people.” Cochrane Dotabase of Systematic Reviews, Iss. 4. Art. No.: CD003840. (2016). DOI: 10.1002/14651858.CD003840.pub5
  12. Kamboj, A.K., Cotter, T.G., Oxentenko, A.S. “Helicobacter pylori: ThePast, Present, and Future in Management.”Mayo Clin. Proc. 92(4) (2017): 599–604. DOI: 10.1016/j.mayocp.2016.11.017
  13. Kan, N.E., Khachatryan, Z.V., Tyutyunyk, V.L, et al. “The use of folates in the prevention of fetal growth retardation during pregnancy.” Medical Council 13 (2018): 65–67. DOI: 10.21518/2079-701х-2018-13-65-67
  14. Kanu, F.A., Hamner, H.C., Scanlon, K.S., et al. “Anemia Among Pregnant Women Participating in the Special Supplemental Nutrition Program for Women, Infants, and Children - United States, 2008–2018.” Morbidity and mortality weekly report 71(25) (2022): 813–819. Available from: [ https://doi.org/10.15585/mmwr.mm7125a1], last accessed 06.10.2023.
  15. Kilicaslan, A.Ö., Kutlu, R., Kilinc, I., et al. “The effects of vitamin D supplementation during pregnancy and maternal vitamin D levels on neonatal vitamin D levels and birth parameters.” J. Matern. Neonatal. Med. 31(13) (2018): 1727–1734. DOI: https://doi.org/10.1080/14767058.2017.1326897
  16. Кoeppel, M., Garcia-Alcalde, F., Glowinski, F., et al. Helicobacter pyllory infection causes characteristic DNA damage patterns in human cells.” Cell.Rep. 11 (2015): 1703–13. Doi: 10.1016/j.celrep.2015.05.030.
  17. Malfertheiner, P., Megraud, F., O’Morain, C.A., et al. “Management of Helicobacter pylori infection – the Maastricht V / Florence Concensus Report.” Gut 66 (2017): 6–30. DOI: 10.1136/gutjnl-2016-312288.
  18. Matsuo, Y., Kido, Y., Yamaoka, Y. “Helicobacter pylori Outer Membrane Protein-Related.” Pathogenesis Toxins (Basel) 9(3).pil 2017: E101. DOI: 10.3390/toxins9030101.
  19. O’Brien, K.O. Maternal, fetal and placental regulation of placental iron trafficking.” Placenta 125 (2022): 47–53. Available from: [https://doi.org/10.1016/j.placenta.2021.12.018], last accessed 06.10.2023.
  20. Pavord, S., Daru, J., Prasannan, N., et al. “BSH Committee. UK guidelines on the management of iron deficiency in pregnancy.” British journal of haematology. 188 (6) (2020): 819–830. Available from: [https://doi.org/10.1111/bjh.16221], last accessed 06.10.2023.
  21. Sangkhae, V., Fisher, A.L., Wong, S., et al. “Effects of maternal iron status on placental and fetal iron homeostasis.” The Journal of clinical investigation. 130 (2) (2020): 625–640. Available from: [https://doi.org/10.1172/JCI127341], last accessed 06.10.2023.
  22. Shah, A., Chester-Jones, M., Dutton, S.J., et al. “Intravenous iron to treat anaemia following critical care: a multicentre feasibility randomised trial.” British journal of anaesthesia. 128 (2) (2022): 272–282. Available from: [https://doi.org/10.1016/j.bja.2021.11.010], last accessed 06.10.2023.
  23. Shi, H., Chen, L., Wang, Y., et al. “Severity of Anemia During Pregnancy and Adverse Maternal and Fetal Outcomes.” JAMA network open 5(2) (2022): e2147046. Available from: [https://doi.org/10.1001/jamanetworkopen.2021.47046], last accessed 06.10.2023.
  24. Sugano, K., Tack, J., Kuipers, E.J., et al. “Kyoto global consensus reporton Helicobacter pylori gastritis.” Gut 64 (2015): 1353–1367. DOI: 10.1136/gutjnl-2015-309252
  25. Voayyedi, P.M., Lacy, B.E., Andrews, C.N., et al. “FCG and CAG Clinical Guideline: Management of Dyspepsia.” Am J Gastroenterol. 112 (2017): 988. DOI: 10.1038/ajg.2017.154

Downloads

Published

2023-09-29

How to Cite

Mishchenko, V., Mishchenko, V., Rudenko, I., & Holovatyuk-Yuzefpolska, I. (2023). Anemia of pregnancy and helicobacteriosis: features of the clinical and laboratory course: Clinical case. REPRODUCTIVE ENDOCRINOLOGY, (69), 53–58. https://doi.org/10.18370/2309-4117.2023.69.53-58

Issue

No. 69 (2023)

Section

Pregnancy and childbirth

License

Copyright (c) 2023 В.П. Міщенко, В.В. Міщенко, І.В. Руденко, І.Л. Головатюк-Юзефпольська

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.